RNA · Atrium Therapeutics, Inc. · Documents
Market Cap
$177.21M
Shares
17.11M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
Key facts
CIK
2093101
CUSIP
04965N104
13F (30d)
64 filings
64 filers
Visit website
Investor relations